Pettigrew, Corinne
Nazarovs, Jurijs
Soldan, Anja
Singh, Vikas
Wang, Jiangxia
Hohman, Timothy
Dumitrescu, Logan
Libby, Julia
Kunkle, Brian
Gross, Alden L.
Johnson, Sterling
Lu, Qiongshi
Engelman, Corinne
Masters, Colin L.
Maruff, Paul
Laws, Simon M.
Morris, John C.
Hassenstab, Jason
Cruchaga, Carlos
Resnick, Susan M.
Kitner-Triolo, Melissa H.
An, Yang
Albert, Marilyn
Funding for this research was provided by:
National Institutes of Health (RF1-AG059869, RF1-AG059869, RF1-AG027161, RF1-AG059869, RF1-AG059869, RF1-AG059869, RF1-AG059869, RF1-AG027161, RF1-AG027161, RF1-AG059869, RF1-AG059869, RF1-AG059869, P01-AG026276, P01-AG003991, RF1-AG059869)
Australian Commonwealth Scientific Industrial Research Organization
National Institute on Aging Intramural Program
Article History
Received: 12 October 2022
Accepted: 12 March 2023
First Online: 28 March 2023
Declarations
:
: Study protocols for all Preclinical AD Consortium sites were approved by each site’s local institutional review board. All participants provided written informed consent. This study was conducted in accordance with the Declaration of Helsinki.
: Not applicable.
: The following authors declare that they have no competing interests: C. Pettigrew, J. Nazarovs, A. Soldan, V. Singh, J. Wang, T. Hohman L. Dumitrescu, J. Libby, B. Kunkle, A.L. Gross, Q. Lu, C. Engelman, P. Maruff, S.M. Laws, J.C. Morris, J. Hassenstab, S.M. Resnick, M.H. Kitner-Triolo, and Y. An. C. L. Masters and M. Albert are advisors to Eli Lilly. C. Cruchaga receives research support from GSK and is a member of the advisory board of Vivid Genomics and Circular Genomics. S. Johnson has served as an advisor to Roche Diagnostics.